YOLFTbeta
Dongwha Pharm.Co.Ltd

Dongwha Pharm.Co.Ltd

000020 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

5,370.00KRW-20.00 (-0.37%)

Price History

Full chart

Market Stats

Previous Close5,390.00
Open5,400.00
Day Range5,360.00 – 5,470.00
52-Week Range4,450.00 – 7,560.00
Volume84.01K
Market Cap140.25B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.28%
Beta0.33
50-Day Avg5,065.40
200-Day Avg5,675.75

About

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOProf. Doh Joon Yoon M.D., Ph.D.
  • Employees825
  • HeadquartersFastFive Tower, Seoul, South Korea, 04522, Korea
  • Websitehttps://www.dong-wha.co.kr

Leadership

  • Prof. Doh Joon Yoon M.D., Ph.D.Chairman of the Board & Co-CEO · b. 1952
  • Mr. Chang-Soo ChoCo-CEO & President · b. 1949

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue234.56B223.37B220.24B213.47B223.20B237.47B258.88B306.60B307.15B272.08B293.02B340.43B361.11B464.87B496.39B
Growth (%)--4.77%-1.40%-3.07%+4.56%+6.39%+9.02%+18.43%+0.18%-11.42%+7.70%+16.18%+6.08%+28.74%+6.78%
Cost of Revenue130.15B124.60B116.53B118.27B126.62B134.29B150.80B190.70B185.42B133.41B143.67B159.44B170.69B250.62B277.85B
Gross Profit104.41B98.77B103.71B95.20B96.58B103.18B108.08B115.91B121.87B138.67B149.35B180.99B190.42B214.26B218.55B
Gross Margin44.51%44.22%47.09%44.60%43.27%43.45%41.75%37.80%39.68%50.97%50.97%53.17%52.73%46.09%44.03%
Operating Expense82.31B88.77B101.64B89.81B91.75B91.92B97.10B104.68B111.95B115.51B126.85B151.08B171.64B200.85B218.29B
Operating Income22.10B10.00B2.06B5.39B4.83B11.26B10.99B11.23B9.92B23.16B22.50B29.92B18.78B13.41B256.75M
Operating Margin9.42%4.48%0.94%2.52%2.17%4.74%4.24%3.66%3.23%8.51%7.68%8.79%5.20%2.88%0.05%
EBITDA------22.49B22.59B28.30B44.64B39.00B35.96B51.16B28.72B32.48B
EBITDA Margin------8.69%7.37%9.21%16.41%13.31%10.56%14.17%6.18%6.54%
Net Income17.68B1.31B1.01B4.94B5.61B26.25B47.01B10.07B9.40B28.51B17.87B20.38B27.44B5.56B8.69B
Net Income Margin7.54%0.59%0.46%2.31%2.51%11.06%18.16%3.28%3.06%10.48%6.10%5.99%7.60%1.20%1.75%
R&D14.08B14.08B12.32B14.23B13.33B13.72B14.08B15.60B16.26B16.91B17.34B19.28B21.55B23.60B25.70B
R&D as % of Total Revenue6.00%6.30%5.59%6.66%5.97%5.78%5.44%5.09%5.29%6.22%5.92%5.66%5.97%5.08%5.18%
Interest Expense00000000206.96M292.15M383.11M370.00M308.01M2.15B4.51B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.07%0.11%0.13%0.11%0.09%0.46%0.91%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets339.43B324.28B316.17B313.07B317.19B324.60B367.23B370.60B376.03B433.81B447.80B461.14B564.97B619.63B642.17B
Total Liabilities109.81B97.29B88.93B83.35B87.07B71.68B70.28B73.20B75.15B91.13B87.67B82.46B157.92B217.96B240.73B
Total Equity229.62B226.99B227.23B229.73B230.12B252.93B296.94B297.09B300.87B331.26B346.93B364.40B371.78B373.37B379.53B
Cash35.13B18.12B28.16B32.62B44.89B35.73B31.59B40.61B37.78B58.60B60.48B34.35B72.32B25.66B13.31B
Net Debt-------------50.17B88.92B

Cash Flow

Currency: KRW2003-12-312004-12-312005-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---46.24B25.23B8.21B13.51B19.83B25.48B-16.52B-4.36B13.28B52.23B36.03B29.22B29.17B-4.00B15.70B
Investing Cash Flow----9.43B-20.94B8.08B-5.10B-979.73M-30.43B16.31B17.22B-11.18B-25.83B-25.41B-43.27B---
Financing Cash Flow----19.82B-21.29B-6.23B-3.96B-6.59B-4.21B-3.92B-3.83B-4.94B-5.46B-8.78B-12.01B---
Capital Expenditure0009.15B6.48B3.24B1.28B885.50M2.50B3.03B3.46B4.80B34.25B21.94B18.43B26.35B74.06B55.30B
Free Cash Flow----------19.89B-8.06B7.78B22.11B11.26B9.13B2.82B-78.07B-39.60B
Dividends Paid---2.79B2.79B2.23B1.96B2.23B2.21B3.04B4.14B3.31B3.31B4.97B4.98B4.98B4.99B4.99B
FCF to OCF---------120.40%184.89%58.56%42.34%31.24%31.24%9.67%1950.09%-252.25%
Dividend Paid to FCF----------15.30%-51.37%42.59%14.98%44.15%54.57%176.61%-6.39%-12.60%

Earnings

Report DateNov 14, 2004Feb 14, 2005Aug 16, 2005Aug 14, 2006Feb 13, 2007May 7, 2007Aug 9, 2007Jan 23, 2008Jun 25, 2010Sep 29, 2010Mar 2, 2011Jul 7, 2011Oct 5, 2011Feb 29, 2012Jun 29, 2012Jul 5, 2012Oct 3, 2012Feb 27, 2013Jun 28, 2013Jul 4, 2013Oct 2, 2013Feb 26, 2014Jun 27, 2014Jul 3, 2014Oct 1, 2014Feb 25, 2015Jun 26, 2015Jul 2, 2015Sep 30, 2015Jun 29, 2016Nov 30, 2016Apr 6, 2017Jul 5, 2017Nov 29, 2017Mar 30, 2018Apr 5, 2018Aug 14, 2018Nov 28, 2018Mar 29, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 11, 2020Apr 2, 2020Aug 11, 2020Nov 12, 2020May 14, 2021Aug 17, 2021Nov 18, 2021May 13, 2022Aug 16, 2022Nov 14, 2022Mar 15, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 19, 2024May 16, 2024Aug 14, 2024Nov 13, 2024Feb 24, 2025May 15, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate33.6077.4064.4046.6064.40118.2028.3251.38-----------------------------------------------------------
EPS Actual2.29265.801.190.8237.207.295.105.8669.12-47.69225.00209.5441.37140.6266.3985.77196.96-302.17146.5942.38-90.88-61.8662.1647.5220.4346.6466.9762.11-29.0635.3651.97123.98115.2228.361434.65170.6427.1642.65124.2466.79-22.788.53288.0281.90243.47425.86197.29226.9816.18189.20217.35214.75115.12452.98271.26213.9653.02107.80127.09-11.10-23.081.24261.2234.5316.38361.47239.74
Surprise-93.18%243.41%-98.15%-98.24%-42.24%-93.83%-81.99%-88.59%-----------------------------------------------------------
TimingAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hours--------------------------------Pre-market-Pre-market----------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap140.25B
Enterprise Value229.46B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.27
Price / Book0.35
Revenue (TTM)513.24B
Gross Profit (TTM)226.24B
EBITDA40.92B
Profit Margin3.52%
Operating Margin7.52%
Return on Equity3.57%
Return on Assets1.77%
Shares Outstanding27.72M
Shares Float18.82M
Beta0.33
Dividend Yield1.28%
Dividend Rate65.00
Payout Ratio9.97%

Dividends

20261×
65.00Mar 24, 2026
20241×
180.00Dec 27, 2024
20231×
180.00Dec 27, 2023
20221×
180.00Dec 28, 2022
20211×
180.00Dec 29, 2021
20201×
180.00Dec 29, 2020
20191×
120.00Dec 27, 2019
20181×
120.00Dec 27, 2018
20171×
150.00Dec 27, 2017
20161×
110.00Dec 28, 2016
20151×
80.00Dec 29, 2015
20141×
80.00Dec 29, 2014
20131×
70.00Dec 27, 2013
20121×
80.00Dec 27, 2012
20111×
100.00Dec 28, 2011
20101×
100.00Dec 29, 2010
20092×
100.00Dec 29, 2009150.00Mar 30, 2009
20081×
140.00Mar 28, 2008
20071×
120.00Mar 29, 2007
20061×
100.00Mar 30, 2006
20051×
100.00Mar 30, 2005
20041×
100.00Mar 30, 2004
20031×
100.00Mar 28, 2003

Stock Splits

  • Jul 2, 20095:1
  • Mar 29, 20011.03:1
  • Mar 30, 20001.03:1